Correlation Between MSP Recovery and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both MSP Recovery and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MSP Recovery and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MSP Recovery and Vivos Therapeutics, you can compare the effects of market volatilities on MSP Recovery and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MSP Recovery with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MSP Recovery and Vivos Therapeutics.

Diversification Opportunities for MSP Recovery and Vivos Therapeutics

-0.53

Correlation Coefficient

MSP Recovery  Vivos Therapeutics

Excellent diversification

The 3 months correlation between MSP and Vivos is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding MSP Recovery and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and MSP Recovery is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MSP Recovery are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of MSP Recovery i.e., MSP Recovery and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between MSP Recovery and Vivos Therapeutics

Assuming the 90 days horizon MSP Recovery is expected to under-perform the Vivos Therapeutics. In addition to that, MSP Recovery is 1.14 times more volatile than Vivos Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Vivos Therapeutics is currently generating about 0.15 per unit of volatility. If you would invest  284.00  in Vivos Therapeutics on April 30, 2025 and sell it today you would earn a total of  188.00  from holding Vivos Therapeutics or generate 66.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.39%
Values	Daily Returns

MSP Recovery  vs.  Vivos Therapeutics

MSP Recovery

Risk-Adjusted Performance

Very Weak

Over the last 90 days MSP Recovery has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Vivos Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with MSP Recovery and Vivos Therapeutics

The main advantage of trading using opposite MSP Recovery and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MSP Recovery position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind MSP Recovery and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.